T1	Claim 1454 1603	In cachectic patients with advanced cancer, oral melatonin 20 mg at night did not improve appetite, weight, or quality of life compared with placebo.
T2	Premise 1271 1453	There were no significant differences between groups for appetite (P = .78) or other symptoms, weight (P = .17), FAACT score (P = .95), toxicity, or survival from baseline to day 28.
R1	Support Arg1:T2 Arg2:T1	
